ABEC’s novel Advanced Therapy Bioreactor (ATB™) brings unprecedented precision, scalability, and
automation to cell therapy processing. Developers can utilize the same platform from initial research &
development through clinical and commercial manufacturing, ensuring consistent, reproducible, and
high-quality cell expansion. The ATB™ reduces development cost and time to market, while enabling the
production of life-saving Advanced Therapy Medicinal Products (ATMPs).